Overweight ACN: Structural floor intact, measured 25-35 bps starter through binary Q4 FY26 catalyst
The structural floor metrics—12.94x forward P/E on 24.4% ROE, $12B FCF with 142% conversion, $1.78B net cash against ~$116B market cap, 3.48% dividend yield—have repeatedly absorbed bearish calls (Aug 7/10/18 Underweight wrong, Aug 21 Underweight partially wrong), making this floor dispositive. Improving technicals (fresh MACD cross Aug 27, rising 10 EMA, no RSI divergence, coiled ATR at $7.60) support participation rather than waiting for confirmation at $177 or $182. Three constraints prevent full Buy conviction: (1) sizing must be inversely proportional to catalyst proximity per Aug 27 reflection—25-35 bps starter rather than 0.8-1%, (2) technical setup is constructive but extended with fragile MACD cross magnitude (7.84 vs 7.83) and RSI at 65 near upper Bollinger, (3) structural concerns (goodwill at 37% of assets growing 16.2% vs revenue 5.6%) are valid but 12-24 month risks, not near-term. Price targets: $201 (200 SMA reclaim) and $215-220 (50% retracement of structural decline).
| Position | Action |
|---|---|
| Current entry zone $185-190 (~$187.50) | Initiate 25-35 bps starter position |
| Pullback to 10 EMA ($182) holding 2+ sessions with RSI >50 | Add 15-20 bps |
| Daily close above upper Bollinger ($191) on volume >5M with MACD histogram expanding | Add 10-15 bps |
| Clean Q4 FY26 print with bookings inflection >5% YoY AND operating margin ≥16.5% AND close above 200 SMA ($201.46) | Post-earnings scale to 100-150 bps total |
| Approaching $200-205 (200 SMA resistance) | Trim 25-30% off position |
| Test of $215-220 if RSI >75 with bearish divergence | Additional 25% trim |
| Adds above $195 | Avoid adding |
| Weekly close below $154 (50 SMA / June 18 gap zone) | Exit entirely (hard structural stop) |
| Price at $179 (1.1 ATR below entry) | Tactical stop triggered |
Accenture offers a rare asymmetric setup where industry-leading returns on equity trade at industry-discount multiples, supported by an already-executed mid-market pivot, a 3.48% dividend yield providing income while waiting for re-rating, and technicals showing short- and medium-term bullish control with a mechanically inevitable golden cross formation.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $182.05 | bullish |
| 50 SMA | $154.38 | bullish |
| 200 SMA | $201.46 | bearish |
| MACD | 7.84 (vs signal 7.83) | bullish |
| MACD Histogram | +0.02 | bullish |
| RSI (14) | 65.12 | neutral |
| Bollinger Upper Band (20,2σ) | $191.13 | bearish |
| Bollinger Middle Band (20 SMA) | $177.41 | neutral |
| Bollinger Lower Band (20,2σ) | $163.69 | bullish |
| ATR (14) | $7.60 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Current zone $185-190 (~$187.50)
Then: Initiate 25-35 bps
Q3 FY26 earnings momentum has inflected with EPS at a 5-quarter high, contradicting bear's consulting softness narrative
↩ rebuts: “Bear points to consulting softness and stalled earnings cycle”
EV: ~25% upside from $187 to $235 if forward P/E re-rates to 16x on $14.66 EPS; 44% upside under Trefis moderate recovery scenario over three years · concedes: Wide options-implied risk band is real and acknowledged; Higher-for-longer rates are a headwind for the sector (though less so for already-compressed ACN); Consulting demand softness is a legitimate concern, addressed by mid-market pivot execution; 200 SMA at $201.46 remains resistance ~7.5% above current price
ACN is a value trap where the P/E discount reflects legitimate earnings durability concerns, not mispricing—the 17% forward EPS growth is heavily buyback-driven (organic EPS growth ~8-10%), goodwill is growing faster than revenue (16.2% vs 5.6%), and the dividend/buyback program has thin FCF coverage (~80%), making it vulnerable to cuts if Q4 guidance disappoints.
EV: -$154 (target, 50 SMA retest on 3-month horizon) · concedes: The current $187 price represents a 58% recovery from the 52-week low of $118; Q3 FY26 EPS did beat the prior quarter's depressed comparison ($3.80 vs $2.25 in Q4 FY25); The dividend yield of 3.48% is above average for the sector
→ vs conservative: Rate headwinds, goodwill concerns, and 200 SMA overhead are already priced in; conservative framing treats resistance levels as sell signals when they are actually targets in a coiled bullish setup
→ vs conservative: Goodwill at $25.3B financed by $3.6B quarterly FCF with 26% D/E; impairment concern requires complete operational collapse at $116B market cap
→ vs conservative: SAIC relative-value argument is momentum-driven, not absolute-value; ACN structurally superior with 40-55% asymmetric upside versus SAIC comparable setup
→ vs neutral: Waiting for pullback to $177 middle Bollinger Band may never materialize on actionable timeframe; MACD crosses don't stay 'fresh' indefinitely and coiled patterns resolve
→ vs neutral: Mid-market pivot via Accenture Edge is 'the cure' not a 'substitute'; two acquisitions executed in past week represents real-time execution, not slow narrative
| Volume (8/27) | 4.93M | bullish |
Support: 169.98 · 163.69 · 154.38 | Resistance: 189.93 · 191.13 · 201.46
ACN is in a bullish short-term recovery within a longer-term corrective phase. Post-June 2026 event (price discontinuity from $154 to $126), the stock has rallied +55% off the low to $187.38. Technical setup shows 6 bullish signals vs 2 bearish and 2 neutral, with MACD freshly crossed bullish, RSI constructive at 65.12, and price riding above the 10 EMA ($182.05) and 50 SMA ($154.38). However, the 200 SMA at $201.46 remains the decisive long-term resistance line, and price is currently wedged against the upper Bollinger Band ($191.13) with ATR compressing — a coiled breakout configuration awaiting directional catalyst. Key levels: resistance at $189.93 / $191.13 / $201.46; support at $182.05 / $177.41 / $169.98.
Market Cap
$116.03 B
TTM EPS
$12.52
Forward EPS
$14.66
TTM P/E
15.14
Forward P/E
12.94
PEG Ratio
1.36
Price/Book
3.64
Beta
1.074
Dividend Yield
3.48%
Book Value/Share
$52.12
52-Week High
$291.09
52-Week Low
$118.15
50-Day MA
$154.82
200-Day MA
$204.56
Gross Margin
~32.0%
Operating Margin
16.96%
Net Margin
10.66%
ROE
24.41%
ROA
10.90%
Q3 FY26 Revenue
$18.72B
Q3 FY26 Diluted EPS
$3.80
TTM Revenue
~$73.10B
Total Assets
$68,807M
Cash & Equivalents
$10,165M
Goodwill
$25,323M
Total Debt
$8,389M
Stockholders' Equity
$31,891M
Debt-to-Equity
26.3%
Current Ratio
1.34
Q3 FY26 Operating Cash Flow
$3,786M
Q3 FY26 Free Cash Flow
$3,600M
FCF (TTM)
$12.09B
Capex % Revenue
~1%
Revenue Growth (YoY)
~5-6%
EPS Growth (Forward)
~17%
Buybacks/Dividends (TTM)
~$8-10B
Strengths
Concerns
Accenture demonstrates superior financial metrics versus IT services peers, with ROE of 24.41%, operating margin of 16.96%, and TTM FCF of $12.09B generated from ~$73.1B in revenue. The balance sheet remains conservative with a 26.3% debt-to-equity ratio and $10.2B in cash, though goodwill represents 37% of total assets following aggressive M&A. Trading at a significant discount to historical multiples (Forward P/E of 12.94 vs. historical 25-30), the stock offers an attractive 3.48% dividend yield and ~17% forward EPS growth potential, balanced against AI disruption concerns, delivery center wage inflation, and goodwill impairment risk.
Macro: Macro data unavailable due to missing FRED API key. Rate environment: Polymarket implies 89% probability of no Fed rate cuts in 2026 ($7.6M volume, +3.3pp WoW), decisively pricing higher-for-longer through year-end. Recession risk: US recession 2026 at 8% (soft-landing base case intact); Japan recession at 20% (-19pp WoW). AI tail risk: bubble burst at 11% (-1.2pp WoW); Anthropic leads AI model race at 69%, OpenAI 10%, xAI 7%. Cross-asset: Gold sold off on Warsh inflation concerns; Asian/European central banks moving toward tighter policy. Macro commentary based on prediction markets and qualitative signals only—not confirmed by FRED data.